further confirmed that TMAO promotes osteoclast differentiation through NF-κB signaling pathway activation (Zhao et al., 2024), while excessive osteoclast activation accelerates bone loss and significantly increases osteoporosis and osteoarthritis risk (Veis and O’Brien, 2023). Here, NFKB1 is linked to osteoarthritis.